A Pilot Study of Fecal Serine-Protease Activity: A Pathophysiologic Factor in Diarrhea-Predominant Irritable Bowel Syndrome

Corazziari, 2004, Definition and epidemiology of functional gastrointestinal disorders, Best Pract Res Clin Gastroenterol, 18, 613, 10.1016/j.bpg.2004.04.012

Drossmann, 1997, Irritable bowel syndrome: technical review for practice guideline development, Gastroenterology, 112, 2120, 10.1053/gast.1997.v112.agast972120

Talley, 2002, Irritable bowel syndrome: a little understood organic bowel disease?, Lancet, 360, 555, 10.1016/S0140-6736(02)09712-X

Nystedt, 1995, The mouse proteinase-activated receptor-2 cDNA and gene, J Biol Chem, 270, 5950, 10.1074/jbc.270.11.5950

Coelho, 2002, Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats, Gastroenterology, 122, 1035, 10.1053/gast.2002.32387

Kawao, 2004, Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2, J Pharmacol Sci, 94, 277, 10.1254/jphs.94.277

Reed, 2003, Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons, J Physiol, 547, 531, 10.1113/jphysiol.2002.032011

Cenac, 2004, PAR2 activation alters colonic paracellular permeability in mice via IFN-γ dependent and -independent pathways, J Physiol, 558, 913, 10.1113/jphysiol.2004.061721

Ait-Belgnaoui, 2005, Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase, Pain, 113, 141, 10.1016/j.pain.2004.10.002

Cenac, 2002, Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2, Am J Pathol, 161, 1903, 10.1016/S0002-9440(10)64466-5

Bohm, 1996, Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2, Biochem J, 314, 1009, 10.1042/bj3141009

Vergnolle, 2004, Modulation of visceral pain and inflammation by protease-activated receptors, Br J Pharmacol, 141, 1264, 10.1038/sj.bjp.0705750

Vergnolle, 2004, Role for proteases and protease-activated receptor-2 in hyperalagaesia induced by supernatants of IBS patients biopsies, Neurogastroenterol Motil, 16, 848A

Spiller, 2000, Increased rectal mucosal endocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome, Gut, 47, 804, 10.1136/gut.47.6.804

Marshall, 2004, Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario, Aliment Pharmacol Ther, 20, 1317, 10.1111/j.1365-2036.2004.02284.x

Dunlop, 2002, Abnormal intestinal permeability in subtypes of diarrhoea predominant IBS, Neurogastroenterol Motil, 14, 586p

Isgar, 1983, Symptoms of irritable bowel syndrome in ulcerative colitis in remission, Gut, 24, 190, 10.1136/gut.24.3.190

Gwee, 1996, Psychometris scores and persistence of irritable bowel after infectious diarrhoea, Lancet, 347, 150, 10.1016/S0140-6736(96)90341-4

Neal, 1997, Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of irritable bowel syndrome: postal survey of patients, BMJ, 314, 779, 10.1136/bmj.314.7083.779

Dunlop, 2003, Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS, Gastroenterology, 125, 1651, 10.1053/j.gastro.2003.09.028

Chadwick, 2002, Activation of the mucosal immune system in irritable bowel syndrome, Gastroenterology, 122, 1778, 10.1053/gast.2002.33579

Dong, 2004, Study of visceral hypersensitivity in irritable bowel syndrome, Chin J Dig Dis, 5, 103, 10.1111/j.1443-9573.2004.00168.x

Barbara, 2004, Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome, Gastroenterology, 126, 693, 10.1053/j.gastro.2003.11.055

Bustos, 1998, Colonic proteinases: increased activity in patients with ulcerative colitis, Medicina (B Aires), 58, 262

Bohe, 1987, Pancreatic and granulocytic endoproteases in faecal extracts from patients with active ulcerative colitis, Scand J Gastroenterol, 22, 59, 10.3109/00365528708991857

Kim, 2003, Expression of protease-activated receptor-2 in ulcerative colitis, Inflamm Bowel Dis, 9, 224, 10.1097/00054725-200307000-00002

Macfarlane, 1988, Contribution of the microflora to proteolysis in the human large intestine, J Appl Bacteriol, 64, 37, 10.1111/j.1365-2672.1988.tb02427.x

Ruseler-van Embden, 2004, Potato tuber proteins efficiently inhibit human faecal proteolytic activity: implication for treatment of peri-anal dermatitis, Eur J Clin Invest, 34, 303, 10.1111/j.1365-2362.2004.01330.x

Balsari, 1982, The fecal microbial population in the irritable bowel syndrome, Microbiologica, 5, 185

Swidsinski, 1999, Alteration of bacterial concentration in colonic biopsies from patients with irritable bowel syndrome (IBS), Gastroenterology, 116, A1

Si-Tahar, 2000, Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells, Gastroenterology, 118, 1061, 10.1016/S0016-5085(00)70359-3

Nystrom, 2001, Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa, Mediators Inflamm, 10, 269, 10.1080/09629350120093740

Kono, 2005, Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity, Am J Surg, 190, 412, 10.1016/j.amjsurg.2005.05.044

Senda, 1993, Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor, Intern Med, 32, 350, 10.2169/internalmedicine.32.350